The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Acquired Infections Testing Market Research Report 2025

Global Acquired Infections Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1906295

No of Pages : 83

Synopsis
The global Acquired Infections Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Acquired Infections Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Acquired Infections Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Acquired Infections Testing in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Acquired Infections Testing include Gen-Probe, Siemens AG, Alere, Cephei, Roche, Abbott Laboratories, Qiagen GmbH, Becton Dickinson and Meridian Bioscience, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Acquired Infections Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acquired Infections Testing.
Report Scope
The Acquired Infections Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acquired Infections Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acquired Infections Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gen-Probe
Siemens AG
Alere
Cephei
Roche
Abbott Laboratories
Qiagen GmbH
Becton Dickinson
Meridian Bioscience, Inc.
bioMerieux
Segment by Type
Disease Testing
Drug-Resistance Testing
Segment by Application
Hospital
Clinics
Ambulatory Surgery Centers (ASC)
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acquired Infections Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acquired Infections Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Disease Testing
1.2.3 Drug-Resistance Testing
1.3 Market by Application
1.3.1 Global Acquired Infections Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Ambulatory Surgery Centers (ASC)
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acquired Infections Testing Market Perspective (2019-2030)
2.2 Acquired Infections Testing Growth Trends by Region
2.2.1 Global Acquired Infections Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Acquired Infections Testing Historic Market Size by Region (2019-2024)
2.2.3 Acquired Infections Testing Forecasted Market Size by Region (2025-2030)
2.3 Acquired Infections Testing Market Dynamics
2.3.1 Acquired Infections Testing Industry Trends
2.3.2 Acquired Infections Testing Market Drivers
2.3.3 Acquired Infections Testing Market Challenges
2.3.4 Acquired Infections Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acquired Infections Testing Players by Revenue
3.1.1 Global Top Acquired Infections Testing Players by Revenue (2019-2024)
3.1.2 Global Acquired Infections Testing Revenue Market Share by Players (2019-2024)
3.2 Global Acquired Infections Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acquired Infections Testing Revenue
3.4 Global Acquired Infections Testing Market Concentration Ratio
3.4.1 Global Acquired Infections Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acquired Infections Testing Revenue in 2023
3.5 Acquired Infections Testing Key Players Head office and Area Served
3.6 Key Players Acquired Infections Testing Product Solution and Service
3.7 Date of Enter into Acquired Infections Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acquired Infections Testing Breakdown Data by Type
4.1 Global Acquired Infections Testing Historic Market Size by Type (2019-2024)
4.2 Global Acquired Infections Testing Forecasted Market Size by Type (2025-2030)
5 Acquired Infections Testing Breakdown Data by Application
5.1 Global Acquired Infections Testing Historic Market Size by Application (2019-2024)
5.2 Global Acquired Infections Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Acquired Infections Testing Market Size (2019-2030)
6.2 North America Acquired Infections Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Acquired Infections Testing Market Size by Country (2019-2024)
6.4 North America Acquired Infections Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acquired Infections Testing Market Size (2019-2030)
7.2 Europe Acquired Infections Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Acquired Infections Testing Market Size by Country (2019-2024)
7.4 Europe Acquired Infections Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acquired Infections Testing Market Size (2019-2030)
8.2 Asia-Pacific Acquired Infections Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Acquired Infections Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Acquired Infections Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acquired Infections Testing Market Size (2019-2030)
9.2 Latin America Acquired Infections Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Acquired Infections Testing Market Size by Country (2019-2024)
9.4 Latin America Acquired Infections Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acquired Infections Testing Market Size (2019-2030)
10.2 Middle East & Africa Acquired Infections Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Acquired Infections Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Acquired Infections Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gen-Probe
11.1.1 Gen-Probe Company Detail
11.1.2 Gen-Probe Business Overview
11.1.3 Gen-Probe Acquired Infections Testing Introduction
11.1.4 Gen-Probe Revenue in Acquired Infections Testing Business (2019-2024)
11.1.5 Gen-Probe Recent Development
11.2 Siemens AG
11.2.1 Siemens AG Company Detail
11.2.2 Siemens AG Business Overview
11.2.3 Siemens AG Acquired Infections Testing Introduction
11.2.4 Siemens AG Revenue in Acquired Infections Testing Business (2019-2024)
11.2.5 Siemens AG Recent Development
11.3 Alere
11.3.1 Alere Company Detail
11.3.2 Alere Business Overview
11.3.3 Alere Acquired Infections Testing Introduction
11.3.4 Alere Revenue in Acquired Infections Testing Business (2019-2024)
11.3.5 Alere Recent Development
11.4 Cephei
11.4.1 Cephei Company Detail
11.4.2 Cephei Business Overview
11.4.3 Cephei Acquired Infections Testing Introduction
11.4.4 Cephei Revenue in Acquired Infections Testing Business (2019-2024)
11.4.5 Cephei Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Acquired Infections Testing Introduction
11.5.4 Roche Revenue in Acquired Infections Testing Business (2019-2024)
11.5.5 Roche Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Detail
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Acquired Infections Testing Introduction
11.6.4 Abbott Laboratories Revenue in Acquired Infections Testing Business (2019-2024)
11.6.5 Abbott Laboratories Recent Development
11.7 Qiagen GmbH
11.7.1 Qiagen GmbH Company Detail
11.7.2 Qiagen GmbH Business Overview
11.7.3 Qiagen GmbH Acquired Infections Testing Introduction
11.7.4 Qiagen GmbH Revenue in Acquired Infections Testing Business (2019-2024)
11.7.5 Qiagen GmbH Recent Development
11.8 Becton Dickinson
11.8.1 Becton Dickinson Company Detail
11.8.2 Becton Dickinson Business Overview
11.8.3 Becton Dickinson Acquired Infections Testing Introduction
11.8.4 Becton Dickinson Revenue in Acquired Infections Testing Business (2019-2024)
11.8.5 Becton Dickinson Recent Development
11.9 Meridian Bioscience, Inc.
11.9.1 Meridian Bioscience, Inc. Company Detail
11.9.2 Meridian Bioscience, Inc. Business Overview
11.9.3 Meridian Bioscience, Inc. Acquired Infections Testing Introduction
11.9.4 Meridian Bioscience, Inc. Revenue in Acquired Infections Testing Business (2019-2024)
11.9.5 Meridian Bioscience, Inc. Recent Development
11.10 bioMerieux
11.10.1 bioMerieux Company Detail
11.10.2 bioMerieux Business Overview
11.10.3 bioMerieux Acquired Infections Testing Introduction
11.10.4 bioMerieux Revenue in Acquired Infections Testing Business (2019-2024)
11.10.5 bioMerieux Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’